维普中文期刊产品整合服务
13篇 您的检索式:作者名="Locker GJ"
    题名 作者 年代 出处 被引量
1Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis 显示文摘Burgmann H Winkler S Locker GJ 1996Clinical Immunology and Immunopathology1996,80,3:1
2Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy显示文摘Wenzel C Locker GJ Schmidinger M 2002Am JKidneyDis2002,39,1:1
3Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofihration in critically ill patients显示文摘Traunmuller F Thalhammer-Scherrer R Locker GJ 2001J Antimicrob Chemother2001,47,2:1
4Prognostic value of MIP-1 alpha,TGF-beta 2,sELAM-1,and sVCAM-1 in patients with gram-positivesepsis 显示文摘Knapp S Thalhammer F Locker GJ 1998Clin Immunol Immunopathol1998,87,2:1
5Lethal Waterhouse-Friderichsen syndrome in posttraumatic asplenia显示文摘Locker GJ Wagner A Peter A 1995J Trauma1995,39,4:1
6Increased serum concentration of soluble CDl4 is a prognostic marker in gram-positive sepsis显示文摘Burgmann H Winkler S Locker GJ 1996Clin Immunol Immunopathol1996,80,31:1
7Pilot-trial of trustuzumab + weekly epidoxorubicin/docetaxel in the neoadjuvant treatment of primary breast cancer-pretiminary results显示文摘Steger GG Wenzel C Locker GJ 2002Proc Am Soc Clin Oncol2002,21,:1
8Increased serum concentration of soluble CD14 is a prognostic marker in Gram-positive sepsis显示文摘 Winkler S Locker GJ 1996Clin Immunol Immunopathol1996,80,:1
9Preoperative chemotherapy with epidoxorubicin,docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer显示文摘Wenzel C Bartsch R Locker GJ 2005Anti-Cancer Drugs2005,16,4:1
10Increased serum concentration of soluble CD14 is a prognostic marker in grampositive sepsis显示文摘Burgmann H Winkler S Locker GJ 1996Clinic Immunol Immunopathol1996,80,31:1
11Phase Ⅰ/Ⅱ trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer 显示文摘Wenzel C Locker GJ Pluschnig U 2002Cancer Chemother Pharmacol2002,50,2:1
12Capeeitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy显示文摘Wenzel C Locker GJ Schmidinger M 2002AmJ Kidney Dis2002,39,1:1
13Oral chemotherapy with capecitabine(Xeloda) in the treatment of metastatic renal cancer failing immunotherapy显示文摘Wenzel C Schmidinger MP Locker GJ 2000Proc Am Soc Clin Oncol2000,19,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费